Yuflyma pre-filled pen SPC information
Quick summary: Yuflyma is a biosimilar medicine to adalimumab used for several chronic inflammatory conditions. This page summarises the product information in plain English, including how it works, common side effects, and key points...
This content is for educational purposes only and does not replace medical advice, diagnosis or treatment from a qualified healthcare professional.
Quick summary: Yuflyma is a biosimilar medicine to adalimumab used for several chronic inflammatory conditions. This page summarises the product information in plain English, including how it works, common side effects, and key points to check in the official leaflet or SPC.
It is given as a subcutaneous injection using a pre-filled pen. Always follow the instructions provided by your healthcare professional and the official product information.
Medical disclaimer: This article is for general information only and does not replace the official Summary of Product Characteristics (SPC), patient leaflet, or advice from a doctor, nurse, or pharmacist. Do not use it to diagnose a condition or make treatment decisions.
Yuflyma pre-filled pen: SPC overview
Yuflyma is a biosimilar medicine used in the management of chronic inflammatory disorders. The pre-filled pen is designed for subcutaneous injection and is intended to make administration more convenient for patients who need ongoing treatment.
The official SPC contains the detailed product information, including indications, administration guidance, and safety information. If you are checking this medicine for a specific condition, the SPC and patient leaflet are the most reliable sources to review with a healthcare professional.
What is Yuflyma?
Yuflyma is a biosimilar to adalimumab. It is used in several inflammatory and autoimmune conditions where reducing inflammation is part of treatment.
As a TNF-α inhibitor, it works by blocking tumour necrosis factor alpha, a substance involved in inflammatory processes. This can help reduce symptoms linked to chronic inflammation.
How does Yuflyma work?
Yuflyma acts as an immunosuppressant and TNF-α inhibitor. By targeting TNF-α, it helps lower inflammation in conditions where the immune system is overactive.
In some treatment plans, it may be used alongside other medicines such as methotrexate. Whether it is used alone or in combination depends on the condition being treated and the prescribing clinician’s plan.
What is Yuflyma used for?
The current content identifies Yuflyma as being used for chronic inflammatory disorders, including:
- Rheumatoid arthritis
- Psoriasis
- Crohn’s disease
- Juvenile idiopathic arthritis
Always confirm the exact licensed indication in the official SPC for the specific product presentation and region.
How to use the Yuflyma pre-filled pen
The pen is intended for subcutaneous injection. The original content highlights these general steps:
- Allow the pen to reach room temperature before use.
- Clean the injection site with an alcohol swab.
- Remove the cap and place the pen at a 90-degree angle to the skin.
- Press the pen firmly against the skin until you hear a click.
- Hold it in place for the recommended time before removing it.
Injection site rotation is commonly advised to help reduce discomfort and local reactions. The exact technique should always follow the official instructions for the device and the guidance given by a healthcare professional.
Possible side effects
Like all medicines, Yuflyma may cause side effects. The original content mentions the following:
- Injection site reactions such as redness, swelling, or pain
- Headache
- Fatigue
- Gastrointestinal disturbances
Side effects can vary from person to person. Any unusual, severe, or persistent reaction should be discussed with a healthcare professional promptly.
What to check before using Yuflyma
The original content notes that patients should discuss their medical history, current medicines, allergies, and existing health conditions with a healthcare provider before treatment. This helps confirm whether the medicine is appropriate and how it should be monitored.
If you are reviewing the SPC, pay close attention to the sections on administration, warnings, interactions, and monitoring requirements.
Yuflyma price and access
The cost of Yuflyma can vary depending on location, pharmacy pricing, and insurance coverage. The original content also notes that assistance or discount programmes may be available for eligible patients.
For the most accurate information, check with a pharmacist, insurer, or local healthcare service rather than relying on general online pricing.
Reviews of Yuflyma 40 mg
Patient feedback in the original content is generally positive, especially regarding symptom improvement and ease of use. Some users report mild injection site reactions, but experiences vary.
Reviews can be helpful for understanding real-world experiences, but they should not replace clinical advice or the official product information.
Safety reminder
Yuflyma is an injectable immunosuppressant medicine, so it is important to use it only as directed and to follow the official SPC and patient leaflet. If anything in the instructions is unclear, ask a doctor, nurse, or pharmacist to explain it before use.
Frequently asked questions
▸ What is Yuflyma used for?
Yuflyma is used for chronic inflammatory conditions such as rheumatoid arthritis, psoriasis, Crohn’s disease, and juvenile idiopathic arthritis, according to the original content.
▸ Is Yuflyma the same as adalimumab?
Yuflyma is described as a biosimilar to adalimumab. For exact product details, check the official SPC and leaflet.
▸ How is the Yuflyma pen given?
It is given as a subcutaneous injection using a pre-filled pen. The original content advises allowing it to reach room temperature, cleaning the site, and following the device instructions carefully.
▸ What side effects are mentioned in the content?
The content mentions injection site reactions, headache, fatigue, and gastrointestinal disturbances.
▸ Can children use Yuflyma?
The original content states that Yuflyma is indicated for juvenile idiopathic arthritis in children. Use in children should always be supervised by a healthcare professional.
▸ Where can I confirm the official product information?
Check the official Summary of Product Characteristics (SPC) and patient leaflet, and ask a pharmacist or prescriber if you need help interpreting them.
Key takeaways
Yuflyma is a biosimilar adalimumab medicine used for several inflammatory conditions. The pre-filled pen is designed for subcutaneous injection, and the official SPC is the best source for detailed product information.
For safe use, always rely on the official leaflet, the SPC, and advice from a qualified healthcare professional.
Medical disclaimer
This content is for educational purposes only. It should not be used as a substitute for professional medical advice, diagnosis or treatment. Always ask a doctor, pharmacist or qualified healthcare professional before starting, stopping or changing any medicine.
Sources and verification
The following sources or official references are listed to support verification of the medicine information discussed in this article.
- Electronic Medicines Compendium (emc) – Yuflyma SPC
- European Medicines Agency – Biosimilar medicines overview
- NHS – Adalimumab overview
- FDA – Biosimilars information
To improve this article with specific references, add a custom field named _aio_sources in the post editor and write one source per line using: Source title|Source URL.
Medicine information can change and may vary depending on country, product formulation, patient history and professional guidance. Always check official medicine information and ask a healthcare professional for personal medical questions.